June 20, 2023

John Dwyer: The Latest Battle on Medicare Reimbursement for Alzheimer’s Drugs

About This Episode

Alzheimer’s is being singled out in Medicare’s decision on reimbursement for patients. President of Global Alzheimer’s Platform Foundation and Co-Founder of UsAgainstAlzheimer’s, John Dwyer spoke with host Meryl Comer about the ramification to patients and how this decision will create greater disparities. Take a listen.

This episode is sponsored by Genentech and Eisai. 

Support the show

BrainStorm Feed

120

The Financial Toll of Caregiving with Ken and Maddy Dychtwald

It is time to treat caregiving as a societal issue rather than a private family matter. More than 32 million Americans are financial caregivers for

LISTEN NOW
119

The Fine Print on Your Prescriptions: What Families Need to Know About Medicare Part D

You picked a Medicare drug plan in December. Then in January, the pharmacist tells you your medication isn’t covered, or that it needs approval first

LISTEN NOW
118

Risky Business: The Costliest Assumptions for Medicare Families

In part one of BrainStorm’s look at Medicare open enrollment, host Meryl Comer talks with Alison Schneider, Director of Market Access Policy and Strategy at

LISTEN NOW